Zhe Jiang Dayang Biotech Group Co., Ltd. (SHE:003017)
China · Delayed Price · Currency is CNY 21.76
-0.08 (-0.37%)
Nov 13, 2026, 12:04 PM CST
SHE:003017 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 353.1 | 441.28 | 353.99 | 382.37 | 131.11 | 131.88 |
Trading Asset Securities | 18.46 | 18.76 | 40.45 | - | 296.48 | 279.77 |
Cash & Short-Term Investments | 371.56 | 460.04 | 394.44 | 382.37 | 427.59 | 411.65 |
Cash Growth | -16.10% | 16.63% | 3.16% | -10.58% | 3.87% | -6.33% |
Accounts Receivable | 149.23 | 163.66 | 127.05 | 103.94 | 138.96 | 134.24 |
Other Receivables | 1.36 | 16.55 | 5.77 | 6.59 | 9.45 | 18.65 |
Receivables | 150.6 | 180.21 | 132.82 | 110.54 | 148.41 | 152.89 |
Inventory | 160.27 | 107.66 | 119.78 | 152.23 | 126.87 | 161.61 |
Prepaid Expenses | - | - | - | 0.32 | 0.35 | 0.25 |
Other Current Assets | 38.16 | 23.41 | 43.51 | 16.18 | 24.94 | 16.3 |
Total Current Assets | 720.59 | 771.31 | 690.55 | 661.63 | 728.16 | 742.7 |
Property, Plant & Equipment | 955.37 | 800.78 | 681.46 | 671.49 | 616.17 | 528.02 |
Long-Term Investments | 99.34 | 100.85 | 121.39 | 54.84 | 2.5 | 2.52 |
Other Intangible Assets | 97.85 | 86.17 | 91.06 | 93.35 | 95.36 | 56.73 |
Long-Term Deferred Tax Assets | 20.9 | 27.35 | 32.31 | 44.17 | 45.46 | 5.54 |
Long-Term Deferred Charges | 1.82 | 1.89 | 2.1 | - | 0.05 | 0.1 |
Other Long-Term Assets | 94.65 | 30.1 | 34.67 | 21.18 | 20.36 | 38.73 |
Total Assets | 1,991 | 1,818 | 1,654 | 1,547 | 1,508 | 1,374 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Accounts Payable | 273.41 | 225.39 | 158.91 | 189.42 | 125.77 | 149.16 |
Accrued Expenses | 20.19 | 38.72 | 22.38 | 21.58 | 28.75 | 11.35 |
Short-Term Debt | 408 | 345.25 | 358.06 | 180.43 | 252.11 | 139.07 |
Current Portion of Long-Term Debt | - | - | 9.51 | - | 30.03 | - |
Current Portion of Leases | - | - | - | 0.87 | - | - |
Current Income Taxes Payable | 4.88 | 0.04 | 0 | 0.07 | - | 0.15 |
Current Unearned Revenue | 7.28 | 5.06 | 3.69 | 5.78 | 8.03 | 7.91 |
Other Current Liabilities | 17.81 | 18.13 | 15.16 | 32.1 | 33.54 | 9.53 |
Total Current Liabilities | 731.57 | 632.58 | 567.7 | 430.26 | 478.24 | 317.16 |
Long-Term Debt | 64.12 | 20.01 | - | 69.06 | - | 39.8 |
Long-Term Leases | 1.23 | 1.64 | - | - | - | 0.87 |
Long-Term Unearned Revenue | 14.98 | 7.51 | 9.01 | 11.35 | 11.96 | 9.6 |
Long-Term Deferred Tax Liabilities | 20.82 | 19.98 | 23.69 | 27.79 | 32.81 | 16.21 |
Total Liabilities | 832.73 | 681.72 | 600.4 | 538.47 | 523.01 | 383.64 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Common Stock | 100.8 | 84 | 84 | 84 | 60 | 60 |
Additional Paid-In Capital | 535.65 | 545.79 | 528.23 | 519.47 | 537.19 | 563.99 |
Retained Earnings | 518.52 | 504.96 | 455.2 | 428.13 | 413.12 | 366.71 |
Treasury Stock | -6.13 | -6.13 | -17.93 | -25.42 | -25.42 | - |
Comprehensive Income & Other | 4.76 | 3.03 | 2.66 | 2.02 | 0.16 | 0.01 |
Total Common Equity | 1,154 | 1,132 | 1,052 | 1,008 | 985.05 | 990.71 |
Minority Interest | 4.19 | 5.1 | 0.99 | - | - | - |
Shareholders' Equity | 1,158 | 1,137 | 1,053 | 1,008 | 985.05 | 990.71 |
Total Liabilities & Equity | 1,991 | 1,818 | 1,654 | 1,547 | 1,508 | 1,374 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Total Debt | 473.35 | 366.9 | 367.56 | 250.37 | 282.14 | 179.74 |
Net Cash (Debt) | -101.79 | 93.14 | 26.87 | 132 | 145.45 | 231.91 |
Net Cash Growth | - | 246.57% | -79.64% | -9.25% | -37.28% | -40.47% |
Net Cash Per Share | -0.91 | 0.94 | 0.27 | 1.36 | 1.49 | 2.30 |
Filing Date Shares Outstanding | 99.61 | 99.61 | 99.61 | 98.1 | 96.1 | 100.8 |
Total Common Shares Outstanding | 99.61 | 99.61 | 99.88 | 97.44 | 96.1 | 100.8 |
Working Capital | -10.98 | 138.74 | 122.85 | 231.38 | 249.92 | 425.53 |
Book Value Per Share | 11.58 | 11.36 | 10.53 | 10.35 | 10.25 | 9.83 |
Tangible Book Value | 1,056 | 1,045 | 961.1 | 914.85 | 889.69 | 933.98 |
Tangible Book Value Per Share | 10.60 | 10.50 | 9.62 | 9.39 | 9.26 | 9.27 |
Buildings | - | 382.66 | 338.1 | 271.87 | 270.86 | 218.74 |
Machinery | - | 627.21 | 574.75 | 544.06 | 569.59 | 451.65 |
Construction In Progress | - | 238.93 | 155.15 | 180.84 | 52.15 | 84.75 |